Efficacy and Safety of Imatinib in Chordoma

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Chordoma
Interventions
DRUG

imatinib

Trial Locations (12)

Unknown

Novartis Investigative Site, Aviano

Novartis Investigative Site, Bologna

Novartis Investigative Site, Candiolo

Novartis Investigative Site, Florence

Novartis Investigative Site, Milan

Novartis Investigative Site, Napoli

Novartis Investigative Site, Padua

Novartis Investigative Site, Pisa

Novartis Investigative Site, Roma

Novartis Investigative Site, Rozzano

Novartis Investigative Site, Torino

Novartis Investigative Site, Lausanne

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY